NCT00819260
Terminated
N/A
A Randomized Clinical Trial Comparing the Harmonic Scalpel to Electrocautery in Breast Reduction Surgery
ConditionsHyperplasia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hyperplasia
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Time for Operation
- Status
- Terminated
- Last Updated
- 12 years ago
Overview
Brief Summary
Purpose: The aims of this randomized clinical trial are to assess and compare 3 different outcomes in women undergoing breast reduction surgery using two different surgical devices: the Harmonic Scalpel and electrocautery.
The three metrics are:
- the time taken to complete the operation
- drainage volume in the days immediately following surgery,
- patient pain in the days immediately following surgery.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients are eligible for enrollment if they agree to provide informed consent, can read and speak English, are at least 18 years of age, and are in generally good health.
Exclusion Criteria
- •under 18 years of age
Outcomes
Primary Outcomes
Time for Operation
Time Frame: day of surgery
Time to complete the breast reduction per breast.
Secondary Outcomes
- Hematoma(first day after surgery)
- Volume of Drainage in Surgical Drains(within one week of surgery)
- Pain Level in Surgical Sites(first week after surgery)
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Comparison of Three Methods for Anterior Cruciate Ligament ReconstructionAnterior Cruciate Ligament RuptureDeficiency of Anterior Cruciate LigamentChronic Instability of KneeAnterior Cruciate Ligament InjuryNCT00529958University of Calgary330
Completed
N/A
European Study on Three Different Approaches to Managing Class 2 Cavities in Primary TeethDental CariesNCT01797458University Medicine Greifswald169
Unknown
Phase 3
A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT)Rectal CancerNCT00601549National Taiwan University Hospital600
Withdrawn
Phase 3
A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C InfectionHepatitis C, ChronicNCT01608737Boehringer Ingelheim
Completed
Phase 3
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)Hepatitis CNCT01297270Boehringer Ingelheim658